Obesity, Cancer, and Why Fat Tissue Is More Than Storage
Excess body fat raises the risk of more than a dozen cancers. The reason has a lot to do with the fact that fat tissue behaves like a hormone-producing organ.
Most people picture body fat as dead weight, padding where extra calories sit, but that picture is wrong. Fat tissue is metabolically busy, and in excess it shifts your whole hormonal environment in ways that, over years, raise your risk of cancer. The link is one of the most consistent findings in cancer research.
The epidemiology is strong
The evidence here is large and old. In a prospective study of more than 900,000 US adults, Calle and colleagues found that people carrying more weight died of a wide range of cancers at higher rates, and estimated that excess weight could account for a meaningful share of cancer deaths [1]. A 2008 meta-analysis by Renehan and colleagues mapped how a rising body mass index tracks with many specific cancers [2], and in 2016 an International Agency for Research on Cancer working group, reported by Lauby-Secretan and colleagues, tied lower body fat to lower risk for thirteen cancers, including breast (after menopause), colon, endometrium, kidney, pancreas, and esophagus [3].
Fat as an endocrine organ
The mechanism starts with a shift in thinking that took hold in the early 2000s, the idea that fat tissue is an endocrine organ. As Kershaw and Flier described in 2004, it pumps hormones and signaling molecules, collectively called adipokines, into the blood [4]. As fat mass grows, the mix and amount of those signals change, and several of those changes favor cancer.
Fat tissue carries an enzyme called aromatase that turns androgens into estrogen, so more fat means more estrogen, which helps explain why obesity links to hormone-sensitive cancers like postmenopausal breast and endometrial cancer. Excess fat also drives insulin resistance, and the body compensates by keeping insulin chronically high, while insulin and its cousin, insulin-like growth factor 1 (IGF-1), act as growth signals that push cells to keep dividing and discourage them from dying off when they should. Overloaded fat tissue runs mildly but chronically inflamed, releasing cytokines that build an environment where damaged cells survive and multiply more easily. One protective adipokine, adiponectin, also falls as fat mass rises, lifting a brake that normally helps restrain abnormal growth.
None of these acts alone; together they tilt the body toward a pro-growth, pro-inflammatory state.
What it means in practice
This isn't a reason to panic so much as a reason to take metabolic health seriously. The same excess fat and high insulin that raise your diabetes risk feed the cancer-risk story too, so the moves that fix one, losing excess fat, lowering insulin, calming inflammation, plausibly help with the other. Risk is about probability, not fate, and you can change a lot of it.
See how our metabolic program works
References
- Calle EE, et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 2003. PMID: 12711737
- Renehan AG, et al. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet. 2008. PMID: 18280327
- Lauby-Secretan B, et al. Body fatness and cancer, viewpoint of the IARC Working Group. N Engl J Med. 2016. PMID: 27557308
- Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab. 2004. PMID: 15181022